GNCAQ — Genocea Biosciences Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$12.49m
- $1.64m
Brief: Genocea Biosciences Reports U.S. FDA Placing GEN-011 IND On Clinical Hold
Brief: Genocea Announces Material Transfer And License Option Agreement With Shionogi For Proprietary Gen-003 Hsv-2 Antigens
Brief: Genocea To Present Long-Term Follow-Up Data From Gen-009 Neoantigen Vaccine At Virtual Asco 2020
U.S. STOCKS ON THE MOVE-Aerpio Pharma, J.C. Penney, Genocea Bio
Genocea Biosciences: Rises on introducing improved cancer therapy
Brief: Genocea Introduces Gen-011, A Transformational T Cell Therapy Designed To Improve On Current Limitations Of Til Therapy
Brief: Genocea Biosciences Inc - Expect Gen-009 Phase 1/2A Part B Readout In Q3
Brief: Genocea Biosciences Expects That Its Existing Cash And Cash Equivalents Are Sufficient To Support Its Operations Into Q1 Of 2021
Brief: Genocea Biosciences Files For Common Stock Offering Of Up To $50 Mln
Brief: Genocea Presents Preclinical Research That Shows Inhibitory Neoantigens Stifle Protective Anti-Tumor Immune Responses
Brief: Genocea Biosciences Inc Files For Offering Of Up To $30.0 Million Of Shares Of Common Stock
Brief: Genocea Posts Qtrly Loss Per Share $0.28
Brief: Genocea Biosciences Provides Corporate Update Including Second-Quarter 2019 Financial Results
Brief: Genocea Biosciences Says Public Offering Of 10.5 Mln Common Shares At $3.50 Per Share
U.S. STOCKS ON THE MOVE-QuickLogic, PG&E, Banks, Jabil
U.S. STOCKS ON THE MOVE-Adobe, Banks, Steel stocks
U.S. STOCKS ON THE MOVE-Allergan, PG&E, Melinta Therapeutics
U.S. STOCKS ON THE MOVE-La-Z-Boy, Adobe, QuickLogic, Axalta Coatings Systems
U.S. STOCKS ON THE MOVE-Adobe, Foresight, Sesen Bio